Posted by Abe Sauer on January 31, 2013 02:22 PM
"That's the one thing you don't do. You don't tell her you took Viagra. I'm pretty sure that's on the warning label."
So went the viagra joke in 2012's feel-good comedy about middle age, This is 40. But jokes about recreational use of the blue ED pill were not the only pharma brand mention in film recently. A new position paper from the mental health watchdog group Citizens Commission on Human Rights (CCHR) asks: "Has the motion picture industry become the newest outlet for pharmaceutical product advertising?"
To make its case, the CCHR points to the critically acclaimed, Oscar-nominated film about mental illness, Silver Linings Playbook.Continue reading...
Posted by Abe Sauer on November 16, 2012 01:01 PM
China is the second latest economy in the world, every significant brand's future is impacted by its growth (or collapse!); but who's got the time?! A weekly potpourri of ten reads that will make you look like a keen China observer during any conversation about China.
This week: Viagra sales, diving pigs, Yao Ming wine, paying more for 'Made in USA', Calvin Klein’s Beijing sneak peak, Single's Day sales package pile-up, PepsiCo, Apple legal loss and more.Continue reading...
Posted by Dale Buss on November 1, 2012 09:03 AM
Pfizer drops on weaker sales of specialty care drugs and emerging market slump, plans to buy back up to $10B in shares.
UK lawmakers prepare to grill Starbucks, Amazon and Google on taxes.
Con Edison makes progress in restoring NYC neighborhoods' power, while MTA offers free fares in bid to get New York moving again.
Apple's Cook fields his A-team before a wary Wall Street.
Avon sees sales drop in China and the U.K.
Barclay's hit with record U.S. fine.
Burger King tests delivery service in Florida.Continue reading...
Posted by Shirley Brady on August 8, 2012 06:50 PM
Android beats Apple for global market share while Samsung becomes top-selling mobile brand in Europe, and Apple and Samsung court battle continues.
Citi tests foreclosure rentals, steps up digital marketing.
Eli Lilly seen as last hope for Alzheimer's drug as Pfizer and J&J bow out.
Betsey Johnson rebounds from bankruptcy with lower-priced collection set for New York Fashion Week.
BlackBerry-maker RIM stock jumps on Samsung rumors.
Carmen Steffens expands fashion brand from Brazil to US.
Chiquita restructuring plan calls for new CEO.
Dairy Queen promotes Orange Julius brand.
Esprit hires Zara exec as new CEO.Continue reading...
Posted by Dale Buss on August 8, 2012 09:02 AM
American Airlines faces record safety penalty, tests hotel baggage delivery service.
Amazon sees pay-off from locker service, looks to acquire more patents.
Apple shelves "Genius" TV campaign, puts former designer on the stand against Samsung and plans to beef up security.
AT&T sees 20,000 employees go on strike.
Bank of America brings discounts to bank statements.
Chiquita seeks new CEO as Undercover Boss star exits.
Chrysler’s Dodge pulls out of NASCAR.Continue reading...
Posted by Dale Buss on August 1, 2012 09:01 AM
Apple and Samsung trade jabs as their high-stakes patent trial begins in San Francisco.
Avon opens talks to settle bribery charges.
BMW warns about tougher market conditions.
Bud Light Premium helps AB InBev sell less beer for more.
Coach suffers from competition from Michael Kors and other handbag purveyors.
Ford brand loyalty validated by new ranking.
Gap fall kids campaign continues bright color theme.
Google buys Wildfire social marketing firm.
Heineken invites creatives to redefine draught beer experience.Continue reading...
Posted by Dale Buss on June 25, 2012 08:55 AM
AB InBev closes in on buying remainder of Mexico's Grupo Modelo for more than $12 billion.
Apple adds Yelp check-ins to iPhone maps app, sees Motorola Mobility patent case shut down by federal judge and retail workers described by NYT as "loyal but short on pay."
Best Buy tries to regain edge before back-to-school season.
BlackBerry owner RIM reportedly considers a plan to split its company in two.
Cadillac surprises with integration of Apple's Siri voice.
Carl's Jr. and Hardee's set Spider-Man movie tie-in.
Dewar's announces three-year partnership with TED.
Dairy Queen gripes about New York menu restrictions as it enters the city.Continue reading...
Posted by Mark J. Miller on May 10, 2012 12:22 PM
Lipitor may be good for folks for helping lower blood cholesterol, but it is also extremely good at making money. Its manufacturer, Pfizer, raked in $12.9 billion annually at Lipitor’s peak, but those cash-cow days when Lipitor was the world's top-selling prescription drug are long gone. More generally known as Atorvastatin, it became a generic back at the end of November.
When a drug goes generic, drug companies generally give up on it right away and move on to the next thing that can potentially rake in the dough. But Pfizer didn’t want to do that. Lipitor had brought in so much, the company was hoping that it could find a way that it could continue to be a revenue stream, including its Lipitor for You patient program, even though Walmart jumped on the generic version as soon as it could do so. Now, don't bother asking your doctor if Lipitor is right for you.Continue reading...